Table 3.
IPF group | |||
Variable | Hazard ratio | 95% CI | P |
Age | 1.025 | 0.915–1.154 | 0.669 |
Sex (Male) | 1.464 | 0.128–16.780 | 0.754 |
Monocyte ratio | 1.466 | 1.027–2.206 | 0.035 |
Honeycomb score | 1.078 | 0.741–1.491 | 0.663 |
GGO score | 0.994 | 0.710–1.349 | 0.971 |
ILD-GAP score | 0.757 | 0.241–1.970 | 0.583 |
%FVC | 0.972 | 0.925–1.015 | 0.206 |
%DLco | 0.991 | 0.954–1.022 | 0.590 |
Non-IPF group | |||
Variable | Hazard ratio | 95% CI | P |
Age | 0.978 | 0.900–1.074 | 0.617 |
Sex (Male) | 0.337 | 0.067–1.707 | 0.183 |
Monocyte ratio | 1.063 | 0.861–1.266 | 0.538 |
Honeycomb score | 1.221 | 0.657–1.844 | 0.449 |
GGO score | 0.953 | 0.713–1.189 | 0.713 |
ILD-GAP score | 2.130 | 1.044–4.174 | 0.038 |
%FVC | 0.990 | 0.954–1.026 | 0.587 |
%DLco | 1.000 | 0.972–1.026 | 0.990 |
Abbreviations: CI confidence interval, GAP gender/age/physiology, GGO ground-glass opacity, ILD interstitial lung disease, IPF idiopathic pulmonary fibrosis, %DLco percentage predicted diffusion capacity of lung for carbon monoxide, %FVC percentage predicted forced vital capacity